Baillie Gifford & CO Insulet Corp Transaction History
Baillie Gifford & CO
- $131 Billion
- Q3 2024
A detailed history of Baillie Gifford & CO transactions in Insulet Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 2,275,701 shares of PODD stock, worth $599 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
2,275,701
Previous 1,886,062
20.66%
Holding current value
$599 Million
Previous $381 Million
39.16%
% of portfolio
0.4%
Previous 0.3%
Shares
4 transactions
Others Institutions Holding PODD
# of Institutions
687Shares Held
62.6MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.23 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.05 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.6 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$767 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA1.74MShares$458 Million0.03% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.3B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...